Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01321944 · ClinicalTrials.gov registry record · NA

Direct to Smoker Outreach in a Health Care Setting

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
590
Enrollment target

NCT01321944: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01321944 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 590 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01321944, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
590 participants
Enrollment target

Study Summary

Tobacco use is the leading preventable cause of death in the United States. Effective treatment for tobacco dependence exists and includes counseling and pharmacotherapy with nicotine replacement, bupropion, or varenicline. The health care system is a key channel for delivering this treatment to smokers. Brief clinical interventions delivered at office visits increase smoking cessation rates, are among the most cost-effective of medical interventions, and are recommended by U.S. Public Health Service. However, physicians and other clinicians often fail to provide them. Clinicians' rates of providing tobacco treatment in ambulatory care can be improved, but even when successful, clinicians can only reach smokers who make an office visit. A health care system might improve its delivery of tobacco treatment by supplementing visit-based efforts with a population-based strategy, using methods proven effective in public health settings. A population of smokers could be identified from electronic health records and offered treatment proactively in a way that maximizes convenience and minimizes barriers such the cost of pharmacotherapy. This study tests the effectiveness of a population-based Direct-to-Smoker (DTS) outreach program provided to smokers in one community health center in Revere, MA, that is part of an integrated health care system. It uses the system's population management tools to identify smokers and proactively offers them evidence-based tobacco treatment that is free and does require making an office visit. A randomized controlled trial will compare the effectiveness of the DTS program to usual primary care. The hypothesis is that adding the DTS program to usual primary care will increase the proportion of smokers who use tobacco dependence treatment and thereby stop smoking.

Interventions

  • OTHER Direct to Smoker Outreach Program

Trial Details

FieldValue
Enrollment Target 590 participants
Start Date 2009-07
Est. Completion 2010-07
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01321944

The ClinicalTrials.gov registry entry for NCT01321944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 590 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Direct to Smoker Outreach Program is the first listed.

NCT01321944 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01321944 about?

NCT01321944 is a clinical study titled "Direct to Smoker Outreach in a Health Care Setting". Tobacco use is the leading preventable cause of death in the United States. Effective treatment for tobacco dependence exists and includes counseling and pharmacotherapy with nicotine replacement, bupropion, or varenicline. The health care system is a key channel for delivering this treatment to smo...

What is the current status of trial NCT01321944?

This trial is currently completed. It is a NA study. The enrollment target is 590 participants. The study started on 2009-07. Estimated completion is 2010-07.

What interventions are being tested in trial NCT01321944?

The interventions under investigation include: Direct to Smoker Outreach Program (OTHER).

Who is sponsoring clinical trial NCT01321944?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.